Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from FDA

FDA advisory panel's conclusion that oral phenylephrine is ineffective means consumers need to think twice when buying cold and flu meds

The ramp-up to cold and flu season is a bad time for consumers to learn that some of their most trusted go-to products don’t actually work.

The Conversation

E-cigs necessary to meet cancer goals

Less smoking means less cancer, especially for Black and LGBTQ+ Americans

Salon

Charged Lemonade, ‘natural caffeine’: the ‘dangerous’ branding of energy drinks must change, experts say

After a student’s death was blamed on a Panera drink, experts say brands making misleading health claims

The Guardian - US

From analysis to the latest developments in health,
read the most diverse news in one place.

3 Top-Rated Growth Stocks To Buy on Every Dip

Growth stocks are down, but don't count them out. Here are three top-rated names worth scooping up when the market pulls back.

Barchart

Mammograms are recommended beginning at age 50. Are women getting them?

71.6% of women 50 and older have had a mammogram in the past two years. The biggest gap in screening rates is between insured and uninsured women.

USAFacts

John Oliver on management consulting firms: ‘They shouldn’t get to be invisible’

The Last Week Tonight host investigates the track record of one of the largest and most influential firms, McKinsey & Company.

The Guardian - US

CVS pulls phenylephrine-only drugs from its store shelves

The cold medicine aisle is about to look a lot different.

The Street

Read news from The Economist, FT, and more,
with one subscription

Modern Medicine Can't Exist Without This Ancient Sea Creature — The Relationship Can't Last Forever

Horseshoe crab blood is used to produce a substance called Limulus amebocyte lysate, which scientists use to test for toxic substances in intravenous drugs.

Inverse

The FDA is proposing a ban on hair relaxers with formaldehyde due to cancer concerns

The federal agency says it is proposing a ban on the use of formaldehyde in hair straighteners and smoothers, which have been linked to increased cancer risks.

WEKU

FDA approves first-of-its-kind new ‘bubble’ treatment for liver cancer

Histotripsy could cause less harmful side effects compared to radiation and chemotherapy, experts say

The Independent UK

FDA calls for new meds for stimulant use

The FDA called for treatments for stimulant use disorder. Doctors say current options are limited

Salon

FDA proposes ban on certain hair products that have been tied to cancer

FDA officials could ban the products as soon as next spring

The Independent UK

FDA is thinking about a ban on hair-straightening chemicals. Stylists say Black women have moved on

The U.S. Food and Drug Administration is considering a ban on certain hair-straightening chemicals that have been used by Black women for years

The Independent UK

Communities can't recycle or trash disposable e-cigarettes. So what happens to them?

Communities across the U.S. are confronting a new vaping problem: how to get rid of millions of disposable e-cigarettes that are considered hazardous waste

The Independent UK

Get all your
news in one place.

100’s of premium titles.
One news app.

Salon

Breaking down the California food ban

Over 10,000 food products could be affected when the ban goes into effect

StockNews.com

3 Revolutionary Biotech Stocks Worth Investing In

The biotech industry's upward momentum is underpinned by the growth of personalized medicine, orphan drugs, innovative biotech tools, and robust government backing. Hence, revolutionary biotech stocks Equillium (EQ), Protalix BioTherapeutics (PLX), and Incyte Corporation (INCY) could make ideal additions to your portfolio at present. Read more….

Zenger

Neuralink’s N1 Brain Implant Poised For Substantial Revenue Growth

Analyst predicts modest adoption and annual revenue of $220 million by 2030 for Neuralink's N1 brain implant.

Investors Business Daily

Intellia Stumbles As It Aims For A First-Ever In CRISPR Gene Editing

The FDA gave Intellia the go-ahead to begin a pivotal study of its gene-editing treatment for a heart disease, but NTLA stock fell.

Get all your
news in one place.

100’s of premium titles.
One news app.

USAFacts

What is naloxone and how is it used in the US?

Tens of thousands die from opioid overdoses in the United States yearly — but medicines like Narcan can reverse overdoses and help reduce the toll.

Salon

Why are we still eating Red Dye No. 3?

The synthetic dye is present in hundreds of candies, as well as snacks like Ding Dongs and Peeps

WEKU

FDA faces pressure to act nationwide on red dye in food

Red No. 3 was banned from cosmetics three decades ago. Consumer advocates question why it's still allowed in food products, including many popular with kids.

The Guardian - US

John Oliver: ‘The immense suffering in Israel and Gaza has been sickening to watch’

The Last Week Tonight host touched on the violence in Israel and Gaza before a main segment on vulnerabilities in the US food safety system.

The Guardian - US

Why is it so hard to get my ADHD medication in the US?

I moved to New York this year and am embroiled in a Kafkaesque ordeal trying to get my meds filled

Investors Business Daily

AI Stocks AVGO And ANET Lead 5 Resilient Names Near Buy Points

AI stocks Broadcom and Arista lead five names near buy points all sporting a flat base, showing resilience in a tough market.

The Independent UK

FDA rules six Vuse Alto e-cigarettes can no longer be sold in the US

Risks associated with the products outweigh the benefits, per the FDA

1 … 44 45 46 47

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.